287 related articles for article (PubMed ID: 28213404)
1. Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism.
Weber GJ; Pushpakumar SB; Sen U
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H874-H885. PubMed ID: 28213404
[TBL] [Abstract][Full Text] [Related]
2. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation.
Weber GJ; Foster J; Pushpakumar SB; Sen U
Pharmacol Res; 2018 Aug; 134():157-165. PubMed ID: 29909116
[TBL] [Abstract][Full Text] [Related]
3. GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Ameliorates Renal Damage Associated with Chronic Obstructive Uropathy.
Lin S; Visram F; Liu W; Haig A; Jiang J; Mok A; Lian D; Wood ME; Torregrossa R; Whiteman M; Lobb I; Sener A
J Urol; 2016 Dec; 196(6):1778-1787. PubMed ID: 27177428
[TBL] [Abstract][Full Text] [Related]
4. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
5. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
6. Exogenous hydrogen sulfide and miR-21 antagonism attenuates macrophage-mediated inflammation in ischemia reperfusion injury of the aged kidney.
Pushpakumar S; Kundu S; Weber G; Sen U
Geroscience; 2021 Jun; 43(3):1349-1367. PubMed ID: 33433751
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of GYY4137 on Renal Ischaemia/Reperfusion Injury through Nrf2-Mediated Antioxidant Defence.
Zhao H; Qiu Y; Wu Y; Sun H; Gao S
Kidney Blood Press Res; 2021; 46(3):257-265. PubMed ID: 33910212
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446
[TBL] [Abstract][Full Text] [Related]
9. Hypertension exaggerates renovascular resistance via miR-122-associated stress response in aging.
Weber GJ; Purkayastha B; Ren L; Pushpakumar S; Sen U
J Hypertens; 2018 Nov; 36(11):2226-2236. PubMed ID: 30256768
[TBL] [Abstract][Full Text] [Related]
10. A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice.
Liu M; Jia Z; Sun Y; Zhang A; Yang T
Mediators Inflamm; 2016; 2016():8145785. PubMed ID: 27340345
[TBL] [Abstract][Full Text] [Related]
11. GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney.
John AMSP; Kundu S; Pushpakumar S; Fordham M; Weber G; Mukhopadhyay M; Sen U
Sci Rep; 2017 Sep; 7(1):10924. PubMed ID: 28883608
[TBL] [Abstract][Full Text] [Related]
12. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen Sulfide Improves Myocardial Remodeling via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.
Liu SY; Duan XC; Jin S; Teng X; Xiao L; Xue HM; Wu YM
Am J Hypertens; 2017 Jan; 30(1):67-74. PubMed ID: 27600580
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide improves colonic barrier integrity in DSS-induced inflammation in Caco-2 cells and mice.
Zhao H; Yan R; Zhou X; Ji F; Zhang B
Int Immunopharmacol; 2016 Oct; 39():121-127. PubMed ID: 27472293
[TBL] [Abstract][Full Text] [Related]
15. Daily therapy with a slow-releasing H
Lin S; Lian D; Liu W; Haig A; Lobb I; Hijazi A; Razvi H; Burton J; Whiteman M; Sener A
Nitric Oxide; 2018 Jun; 76():16-28. PubMed ID: 29522906
[TBL] [Abstract][Full Text] [Related]
16. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-31 Regulates Immunosuppression in Ang II (Angiotensin II)-induced Hypertension by Targeting Ppp6C (Protein Phosphatase 6c).
Li X; Cai W; Xi W; Sun W; Shen W; Wei T; Chen X; Sun L; Zhou H; Sun Y; Chen W; Gao P; Wang H; Li Q
Hypertension; 2019 May; 73(5):e14-e24. PubMed ID: 30929511
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide in paraventricular nucleus attenuates blood pressure by regulating oxidative stress and inflammatory cytokines in high salt-induced hypertension.
Liang YF; Zhang DD; Yu XJ; Gao HL; Liu KL; Qi J; Li HB; Yi QY; Chen WS; Cui W; Zhu GQ; Kang YM
Toxicol Lett; 2017 Mar; 270():62-71. PubMed ID: 28185984
[TBL] [Abstract][Full Text] [Related]
19. MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.
Kundu S; Pushpakumar S; Sen U
Nitric Oxide; 2015 Apr; 46():172-85. PubMed ID: 25659756
[TBL] [Abstract][Full Text] [Related]
20. The antihypertension effect of hydrogen sulfide (H
Zhu ML; Zhao FR; Zhu TT; Wang QQ; Wu ZQ; Song P; Xu J; Wan GR; Yin YL; Li P
Life Sci; 2021 Feb; 267():118831. PubMed ID: 33253721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]